GLP-1 and Sleep: How Weight Loss Changes Rest, Energy and Sleep Apnoea

Last updated: 8 August 2026

TL;DR: GLP-1 medication affects sleep in two directions. Early on, reduced food intake can leave some people feeling tired. Over time, weight loss tends to improve sleep, and it significantly reduces obstructive sleep apnoea, an evidence-backed benefit. Better sleep and more daytime energy then compound with the other changes weight loss brings.

Sleep and energy are among the changes people feel most as weight comes off, and the picture is not one-directional. This guide separates the early tiredness some experience from the longer-term improvements, and covers the strong evidence on sleep apnoea. It is educational and does not replace advice from your prescriber.

How Does GLP-1 Medication Affect Sleep?

GLP-1 treatment affects sleep mainly through weight loss, which tends to improve sleep quality over time, though the early weeks can feel different. As excess weight reduces, breathing during sleep often improves and rest becomes more restorative.

The relationship runs both ways: reduced food intake early on can leave some people low on energy, while the medium-term trend for many is better sleep. Understanding both phases helps you interpret what you are experiencing rather than worrying about it.

Why Might You Feel Tired in the Early Weeks?

Early tiredness is usually about intake: eating much less can mean lower energy while your body adjusts. It typically settles as you find an eating pattern that meets your needs on a smaller appetite.

Some people also report daytime sleepiness; a real-world cohort analysis (Journal of Diabetes & Metabolic Disorders, 2026) examined an association between GLP-1 use and hypersomnolence. The practical response is to make sure you are eating enough, particularly protein, staying hydrated, and not under-fuelling. If fatigue is significant or persistent, it is worth raising with your prescriber rather than assuming it is just the medicine.

How Does Weight Loss Improve Sleep Apnoea?

Weight loss reduces the severity of obstructive sleep apnoea, and GLP-1 treatment has strong trial evidence here. According to SURMOUNT-OSA (Malhotra et al., New England Journal of Medicine, 2024), tirzepatide significantly reduced obstructive sleep apnoea severity in people with obesity.

The finding is supported more broadly: a systematic review and meta-analysis (Journal of Translational Medicine, 2025) found GLP-1 medicines improved obstructive sleep apnoea outcomes in people with obesity and type 2 diabetes. Reducing sleep apnoea can transform daytime energy, because the underlying problem, repeatedly interrupted breathing and sleep, is being addressed. This is a licensed use of tirzepatide in some contexts, so it is worth discussing with a clinician if sleep apnoea affects you.

How Do Better Sleep and Energy Compound Over Time?

As sleep improves, daytime energy rises, and that feeds into the other changes weight loss brings. Better rest supports mood, appetite regulation and the motivation to stay active, which in turn supports further progress.

This is one of the compounding effects that make results durable: easier movement, better sleep and steadier energy reinforce each other over months. The early tiredness, for those who experience it, is usually a short phase; the longer arc for many is more energy, not less, as weight and sleep both improve.

When Should You Raise Fatigue With Your Prescriber?

Persistent or significant fatigue is worth a conversation, because it is not always just the medicine. Tiredness can have other causes that deserve checking.

• Fatigue that is severe, persistent, or worsening rather than settling.
• Tiredness alongside other symptoms such as dizziness or feeling faint.
• Signs you may be under-eating or not getting enough protein.
• Sleep that is poor despite weight loss, which may need separate assessment.

Your prescriber can check whether intake, dose or another factor is involved. For the nutrition side of maintaining energy, see the related eating and protein guides.

Related Guides

• Do GLP-1 Medications Have Benefits Beyond Weight Loss?
• How to Get Enough Protein on GLP-1 Medication When You're Not Hungry
• Returning to Exercise on GLP-1: How to Start Moving Again
• How to Manage Common GLP-1 Side Effects: A Practical Patient Guide
• Life After the First Dose: A Practical Guide to Long-Term GLP-1 Routines

Key Takeaways

• GLP-1 medication affects sleep in two directions: possible early tiredness, later improvement.
• Early fatigue is usually about reduced intake and tends to settle.
• Weight loss reduces obstructive sleep apnoea severity, with strong trial evidence.
• SURMOUNT-OSA showed tirzepatide significantly reduced sleep apnoea severity in obesity.
• Better sleep and energy compound with the other changes weight loss brings.
• Persistent or significant fatigue should be raised with your prescriber.

Frequently Asked Questions

Why am I tired on Mounjaro or Wegovy?
Early tiredness is usually about eating much less while your body adjusts, and it tends to settle as you find an eating pattern that meets your needs. Some people report daytime sleepiness. Make sure you are eating enough, especially protein, and raise significant or persistent fatigue with your prescriber.

Does weight loss medication help sleep apnoea?
Yes. Weight loss reduces obstructive sleep apnoea severity, and the evidence is strong: SURMOUNT-OSA (NEJM, 2024) showed tirzepatide significantly reduced sleep apnoea severity in people with obesity, supported by later meta-analysis. If sleep apnoea affects you, discuss it with a clinician.

Does GLP-1 medication improve sleep?
Over time, for many people, yes, mainly through weight loss improving breathing during sleep and reducing sleep apnoea. The early weeks can feel different, with some tiredness from reduced intake, but the longer-term trend is often better sleep and more daytime energy.

When should I worry about tiredness on a weight loss injection?
Raise it with your prescriber if fatigue is severe, persistent or worsening, comes with dizziness or feeling faint, or suggests you are under-eating. Tiredness is not always just the medicine, and your prescriber can check whether intake, dose or another factor is involved.

Published by Bolt Pharmacy, a GPhC-registered UK pharmacy. Sources: SURMOUNT-OSA, New England Journal of Medicine (2024); GLP-1 for obstructive sleep apnoea systematic review and meta-analysis, Journal of Translational Medicine (2025); GLP-1 use and hypersomnolence cohort analysis, Journal of Diabetes & Metabolic Disorders (2026). Educational only; not a substitute for advice from your prescriber. Reflects published information as of August 2026.